Mirum Pharmaceuticals (MIRM) Revenue (QoQ) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.35% |
| Dec 31, 2025 | 11.97% |
| Sep 30, 2025 | 4.09% |
| Jun 30, 2025 | 14.52% |
| Mar 31, 2025 | 12.24% |
| Dec 31, 2024 | 10.00% |
| Sep 30, 2024 | 16.05% |
| Jun 30, 2024 | 12.50% |
| Mar 31, 2024 | -0.48% |
| Dec 31, 2023 | 45.74% |
| Sep 30, 2023 | 27.28% |
| Jun 30, 2023 | 18.67% |
| Mar 31, 2023 | 13.23% |
| Dec 31, 2022 | 48.59% |
| Sep 30, 2022 | 7.41% |
| Jun 30, 2022 | 35.62% |
| Mar 31, 2022 | 310.83% |
| Dec 31, 2021 | -37.24% |
| Sep 30, 2021 | -54.55% |